<DOC>
	<DOCNO>NCT00589810</DOCNO>
	<brief_summary>In replication study Cleveland Clinic , seek collaborate validate finding CardioGene Study independent cohort patient undergone bare metallic stenting .</brief_summary>
	<brief_title>Whole Genome Association Study Identify Validate Genes Restenosis : CardioGene Validation Proposal</brief_title>
	<detailed_description>Dr. Elizabeth Nabel , Dr. Santhi K. Ganesh colleague National Institutes Health complete genetic association study , entitle CardioGene Study , use 100,000 SNPs span entire human genome subject restenosis percutaneous intervention use bare metallic stent ( Ganesh SK , 2004 ) . In replication study Cleveland Clinic , seek collaborate validate finding CardioGene Study independent cohort patient undergone bare metallic stenting . This study examine sample clinical data collect subject undergoing cardiac catheterization meet study criterion , select GeneBank . In Genebank repository , subject inform sample may use indefinitely study consent data/samples share investigator Cleveland Clinic collaborating institution . No information might identify subject share collaborate investigator sample share de-identified manner , use assign study number .</detailed_description>
	<mesh_term>Coronary Restenosis</mesh_term>
	<criteria>Age &gt; 18 informed consent participation Genetics Research BMS place de novo ( previously untreated type PCI ) lesion within native coronary artery ( within bypass graft ) lesion Outcome data available 12 month For case control : Age le 18 No informed consent Genetic Research BMS place bypass graft . Radiation lesion treat bare metal stent time index stenting ( continue next page ) A drugeluting stent within overlap target lesion BMS place time index stenting . Participation cardiovascular study time index stenting procedure day 365 post stenting TVR , ever occur first , meet one following : Placebo v active drug study restenosis rate , atheroma volume thrombosis , unblinding information available study result unknown active drug show positive effect . Placebo vs active drug know effect restenosis rate , atheroma volume thrombosis unblinding information available . Blinded randomize study involve two class drug result unknown result study show superiority one treatment arm unblinding information available . For control : addition exclusion : prior history TVR ( TRRS ) positive stress test cath &gt; equal 50 % stenosis target lesion within one year index bare metal stenting . Subjects report deceased Interventional Registry chart abstraction without negative cath result negative stress test result 5 month 13 month post index procedure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>ISR</keyword>
	<keyword>in-stent restenosis</keyword>
	<keyword>restenosis</keyword>
	<keyword>BMS</keyword>
	<keyword>bare metal stent</keyword>
	<keyword>revascularization</keyword>
	<keyword>genetic</keyword>
	<keyword>cardiac catheterization</keyword>
</DOC>